Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moderna COVID-19 Vaccine Transmission Study (Prevent COVID U)
NCT04811664Phase 3Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Mar 2021
- Primary completion
- Dec 2021
- Modality
- Vaccines & Immunotherapeutics, mRNA Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of elasomeran in Coronavirus Disease 2019 (COVID-19), sponsored by National Institute of Allergy and Infectious Diseases. Started Mar 2021; status: completed.
02
Drugs
elasomeran
03
Conditions
Coronavirus Disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04811664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04811664.